![](/img/cover-not-exists.png)
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131I-metaiodobenzylguanidine
Huibregtse, Kelly E., Vo, Kieuhoa T., DuBois, Steven G., Fetzko, Stephanie, Neuhaus, John, Batra, Vandana, Maris, John M., Weiss, Brian, Marachelian, Araz, Yanik, Greg A., Matthay, Katherine K.Volume:
66
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2016.07.017
Date:
October, 2016
File:
PDF, 369 KB
english, 2016